Beneficient

AI-generated fair value estimate for this company.

Method: Asset-based NAV analysis: Total Assets $250.94M vs Total Liabilities $344.5M (quarter ended 6/30/26) yields a shareholders deficit of -$93.57M against 15.46M shares outstanding, and the $584.0M gross ExAlt Loan Portfolio carries a $414.4M allowance for credit losses (net carrying value $169.7M) against $195.5M of underlying trust collateral NAV, so on a straight asset/liquidation basis common equity has no positive residual backing.

Reasoning: Beneficient discloses substantial doubt about its ability to continue as a going concern, is in default on its HCLP related-party loan with pending litigation, and posts negative revenue/net losses, making a DCF meaningless; an asset/liquidation-based NAV approach is the only rigorous method for a company whose liabilities already exceed its assets, and the calculation shows no fundamental equity value (the $1.46 market price reflects speculative option value on litigation/restructuring outcomes, not asset backing).